Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized StudyDavid E. Griffith, Kevin Winthrop, Adam T. Hill et al.|American Journal of Respiratory and Critical Care Medicine|2018Cited by 343
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung DiseaseKenneth N. Olivier, Richard J. Wallace, Matthias Salathé et al.|American Journal of Respiratory and Critical Care Medicine|2016Cited by 246